Hansa Biopharma and Medison Pharma announce multiregional commercialization partnership for Hansa's desensitization treatment for kidney transplant in Central Eastern Europe and Israel

/PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, and Medison Pharma, a...

Related Keywords

Sweden ,Hungary ,Stockholm ,United Kingdom ,Israel ,Croatia ,Slovenia ,Poland ,Jordan ,Hansa Biopharma ,Medison Pharma ,Klaus Sindahl ,Katja Margell ,Meir Jakobsohn ,Linkedin ,European Medicines Agency Priority ,Israel Ministry Of Health ,European Union ,Corporate Communications ,European Medicines Agency ,European Medicine Agency ,Head Of Corporate Communications ,Nasdaq Stockholm ,Central Eastern Europe ,Central Eastern European ,Human Leukocyte Antigens ,European Marketing Authorization ,European Medicine ,End Stage Renal Disease ,Englj Med ,American Society ,Hansa Biopharma Ab ,